Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.

MLA

Phillips, Kelly-Anne, et al. “Anti-Müllerian Hormone Serum Concentrations of Women with Germline BRCA1 or BRCA2 Mutations.” Human Reproduction (Oxford, England), vol. 31, no. 5, May 2016, pp. 1126–32. EBSCOhost, https://doi.org/10.1093/humrep/dew044.

APA

Phillips, K.-A., Collins, I. M., Milne, R. L., McLachlan, S. A., Friedlander, M., Hickey, M., Stern, C., Hopper, J. L., Fisher, R., Kannemeyer, G., Picken, S., Smith, C. D., Kelsey, T. W., & Anderson, R. A. (2016). Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations. Human Reproduction (Oxford, England), 31(5), 1126–1132. https://doi.org/10.1093/humrep/dew044

Chicago

Phillips, Kelly-Anne, Ian M Collins, Roger L Milne, Sue Anne McLachlan, Michael Friedlander, Martha Hickey, Catharyn Stern, et al. 2016. “Anti-Müllerian Hormone Serum Concentrations of Women with Germline BRCA1 or BRCA2 Mutations.” Human Reproduction (Oxford, England) 31 (5): 1126–32. doi:10.1093/humrep/dew044.